Panlin Capital
Private equity investment management firm focused on investing in and growing innovative biotechnology companies
About This Fund
Panlin Capital is an institutional investor (Growth Equity) founded in 2010 and headquartered in Shanghai, china. Private equity investment management firm focused on investing in and growing innovative biotechnology companies. The company aims to provide financing and strategic guidance to its portfolio companies, driving their growth and success. It has developed an investment strategy and a network of industry connections to identify and capitalize on promising investment opportunities. Practice areas include Investment Industry. The firm operates as Private Equity Funds. Key investment sectors include Biotech / Biopharma. The firm typically invests at the Growth and Private Equity stage(s).
Investment Focus
Preparing to pitch Panlin Capital?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →